Tord Inghardt

872 total citations
28 papers, 667 citations indexed

About

Tord Inghardt is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Tord Inghardt has authored 28 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Hematology. Recurrent topics in Tord Inghardt's work include Carbohydrate Chemistry and Synthesis (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Tord Inghardt is often cited by papers focused on Carbohydrate Chemistry and Synthesis (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Tord Inghardt collaborates with scholars based in Sweden, United Kingdom and Australia. Tord Inghardt's co-authors include Johanna Deinum, Petter Björquist, Torbjörn Frejd, Sven Nylander, Djordje Müsil, Lennart Sjölin, Yafeng Xue, Torbjoern Frejd, Bengt Kull and Fabrizio Giordanetto and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Journal of the American College of Cardiology.

In The Last Decade

Tord Inghardt

28 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tord Inghardt Sweden 17 269 182 162 162 132 28 667
George Boykow United States 16 331 1.2× 371 2.0× 226 1.4× 172 1.1× 243 1.8× 29 1.1k
Barbara J. Haertlein United States 14 270 1.0× 176 1.0× 271 1.7× 63 0.4× 125 0.9× 24 734
Edward C. Giardino United States 13 175 0.7× 137 0.8× 174 1.1× 56 0.3× 90 0.7× 20 507
Robert A. Galemmo United States 19 494 1.8× 143 0.8× 262 1.6× 96 0.6× 90 0.7× 46 1.0k
Lorraine Leblond Canada 14 243 0.9× 237 1.3× 321 2.0× 122 0.8× 45 0.3× 21 835
Chris Dockendorff United States 17 458 1.7× 161 0.9× 951 5.9× 71 0.4× 77 0.6× 50 1.5k
Kurt Hilpert Switzerland 12 235 0.9× 109 0.6× 162 1.0× 29 0.2× 75 0.6× 19 478
Parvathy Sasikumar United Kingdom 15 252 0.9× 149 0.8× 75 0.5× 28 0.2× 83 0.6× 26 746
Rainer Metternich Switzerland 17 312 1.2× 181 1.0× 570 3.5× 55 0.3× 51 0.4× 28 973
Zhouling Xie China 16 277 1.0× 55 0.3× 158 1.0× 42 0.3× 49 0.4× 46 643

Countries citing papers authored by Tord Inghardt

Since Specialization
Citations

This map shows the geographic impact of Tord Inghardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tord Inghardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tord Inghardt more than expected).

Fields of papers citing papers by Tord Inghardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tord Inghardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tord Inghardt. The network helps show where Tord Inghardt may publish in the future.

Co-authorship network of co-authors of Tord Inghardt

This figure shows the co-authorship network connecting the top 25 collaborators of Tord Inghardt. A scholar is included among the top collaborators of Tord Inghardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tord Inghardt. Tord Inghardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleming, Cassandra L., Yongjin Xu, Tord Inghardt, et al.. (2024). All-photonic kinase inhibitors: light-controlled release-and-report inhibition. Chemical Science. 15(18). 6897–6905. 5 indexed citations
2.
Jurva, Ulrik, Lars Weidolf, Anja Ekdahl, et al.. (2023). Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and Humans. Drug Metabolism and Disposition. 51(4). 464–479. 6 indexed citations
3.
Kajanus, Johan, Thomas Antonsson, Leif Carlsson, et al.. (2019). Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents. Bioorganic & Medicinal Chemistry Letters. 29(10). 1241–1245. 7 indexed citations
4.
Nylander, Sven, S. KENNETH PEHRSSON, Tord Inghardt, et al.. (2015). A SPECIFIC ANTIDOTE FOR TICAGRELOR. Journal of the American College of Cardiology. 65(10). A253–A253. 1 indexed citations
5.
Buchanan, Andrew, Philip M. Newton, S. KENNETH PEHRSSON, et al.. (2015). Structural and functional characterization of a specific antidote for ticagrelor. Blood. 125(22). 3484–3490. 64 indexed citations
6.
Giordanetto, Fabrizio, et al.. (2014). Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. 24(16). 3936–3943. 19 indexed citations
7.
Barlaam, Bernard, Sabina Cosulich, Sébastien L. Degorce, et al.. (2014). Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours. Bioorganic & Medicinal Chemistry Letters. 24(16). 3928–3935. 17 indexed citations
8.
Nylander, Sven, Bengt Kull, Jan‐Arne Björkman, et al.. (2012). Human target validation of phosphoinositide 3‐kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor. Journal of Thrombosis and Haemostasis. 10(10). 2127–2136. 102 indexed citations
9.
10.
Egner, Bryan J., et al.. (2009). Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition. Bioorganic & Medicinal Chemistry Letters. 19(15). 4268–4273. 7 indexed citations
11.
Egner, Bryan J., et al.. (2009). Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities. Bioorganic & Medicinal Chemistry Letters. 19(15). 4274–4279. 12 indexed citations
12.
Mattsson, Christer, Tord Inghardt, Margareta Elg, & Johanna Deinum. (2009). Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637. Thrombosis and Haemostasis. 101(6). 1051–1059. 30 indexed citations
13.
Egner, Bryan J., et al.. (2008). Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent Melanin-Concentrating Hormone Receptor 1 (MCH-R1) antagonists. Bioorganic & Medicinal Chemistry Letters. 18(17). 4859–4863. 6 indexed citations
14.
Giordanetto, Fabrizio, Lars-Olof Larsson, Anna Linusson, et al.. (2007). Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(15). 4232–4241. 23 indexed citations
15.
Campbell, Robert F., et al.. (2003). Enzymatic resolution of substituted mandelic acids. Tetrahedron Letters. 44(29). 5477–5481. 26 indexed citations
16.
17.
Björquist, Petter, et al.. (1997). Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1341(1). 87–98. 23 indexed citations
18.
Inghardt, Tord & Torbjörn Frejd. (1991). Organoaluminium induced ring-opening of epoxypyranosides. V. Formal total synthesis of antimycin A3 and synthesis of (+)-blastmycinone.. Tetrahedron. 47(32). 6483–6492. 20 indexed citations
19.
Inghardt, Tord, Torbjörn Frejd, & Göran Svensson. (1991). Organoaluminium induced ring-opening of epoxypyranosides. IV. Synthesis and structure of γ- hydroxy-lsoleucine stereoisomers and their corresponding lactones.. Tetrahedron. 47(32). 6469–6482. 19 indexed citations
20.
Inghardt, Tord & Torbjörn Frejd. (1990). Oxirane Ring Opening of Anhydrosugars with Alkynyl- and Alkenylaluminates. Synthesis. 1990(4). 285–291. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Boykow Breakdown of academic impact, for papers by Barbara J. Haertlein Breakdown of academic impact, for papers by Edward C. Giardino Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Lorraine Leblond Breakdown of academic impact, for papers by Chris Dockendorff Breakdown of academic impact, for papers by Kurt Hilpert Breakdown of academic impact, for papers by Parvathy Sasikumar Breakdown of academic impact, for papers by Rainer Metternich Breakdown of academic impact, for papers by Zhouling Xie
Rankless by CCL
2026